1. Porter, C. C., Totaro, J. A., and Stone, C. A. (1963) Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice. J. Pharmacol. Exp. Ther. 140, 308–316.
2. Porter, C. C., Totaro, J. A., and Burcin, A. (1965) The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labelled methyldopa or 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 150, 17–22.
3. Stone, C. A., Stavorski, J. M., Ludden, C. T., Wengler, H. C., Ross, C. A., Totaro, J. A., and Porter, C. C. (1963) Comparison of some pharmacological effects of certain 6-substituted dopamine derivatives with reserpine, guanethidine and metaraminol. J. Pharmacol. Exp. Ther. 142, 147–156.
4. Tranzer, J. P. and Thoenen, H. (1967) Ultra-morphologische Veranderungen der sympa-tischen Nervendigunden der Katze nach Vorbehandlung mit 5- und 6-hydroxy-dopamin. Naunyn-Schmiedebergs Arch. Pharmakol. Exp. Pathol. 257, 343–344.
5. Thoenen, H. and Tranzer, J. P. (1968) Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedebergs Arch. Pharmakol. Exp. Pathol. 261, 271–288.